- US Stock Market Preview | All Three Major Index Futures Rise, Nvidia (NVDA.US) Teams Up with Wall Street to Leverage $500 Billion, Yen Approaches 160 Again
- Egypt's Ministry of Energy: Egypt will launch the Meleiha gas plant next month.
- CME Group to Launch 24-Hour Silver Trading on September 11
- ManpowerGroup names Paychex CEO John B. Gibson Jr. to board
- 374Water signs MOU with Arcadis to pursue federal PFAS destruction projects
- 1606 Corp taps MDM Group to market planned Lufkin 55 MW powered-site acquisition to AI data center buyers
- LivePerson urges shareholders to back SoundHound merger ahead of Aug. 20 vote
- IBM, Together AI sign $240 million multi-year deal to scale open-source AI inference on IBM Cloud
- TASKUS, INC. <TASK.O>: MORGAN STANLEY RAISES TARGET PRICE TO $7.00 FROM $6.00
- Kalaris net loss widens to $11.52 million in Q2 FY26
- HIMS & HERS HEALTH INC <HIMS.N>: MORGAN STANLEY RAISES TARGET PRICE TO $28.00 FROM $21.00
- DEFINITIVE HEALTHCARE <DH.O>: MORGAN STANLEY CUTS TARGET PRICE TO $1.50 FROM $2.50
- TRX staking declines as TRON’s Q2 USDT transfers hit $2.1T: Can demand beat supply?
- Reuters survey: The yield on the US two-year Treasury note is expected to drop to 4.07% within three months, 3.92% within six months, and 3.80% within one year (the July survey indicated 4.00%, 3.90%, and 3.85% respectively).
- Reuters survey: 18 out of 22 bond strategists say that over the next three months, the yield on the US 10-year Treasury bond is more likely to exceed expectations than fall below them.
- Reuters survey: The yield on 10-year US Treasury bonds is expected to fall to 4.50% in three months and remain at that level for the following three months, dropping to 4.34% after one year (July survey figures were 4.48%, 4.48%, and 4.39%, respectively).
- Analyst Who Called $3.37 XRP Top States What to Expect If XRP Breaks $1.01
- Samudera Shipping unit BOS orders new 696-TEU container vessel for 2028 delivery
- Bitcoin decouples from software stocks, signaling investor shifts
- RIOT PLATFORMS, INC. <RIOT.O>: ATB CORMARK CAPITAL MARKETS RAISES TARGET PRICE TO $36 FROM $28
- Foreign Media: After XRP Accounts Surpass 8 Million, the Top 1% Threshold Drops to 44,771 Tokens
- web3: XLM falls below key support, derivatives data weakens
- Syra Health Q2 FY26 swings to profit of $250,242; revenue rises 23% to $2.4 million
- US Dollar: CPI keeps USD in tight ranges – OCBC
- Token Unlocks This Week: Why Supply Share Matters More Than Value
- CALFRAC WELL SERVICES LTD <CFW.TO>: ATB CORMARK CAPITAL MARKETS RAISES TO OUTPERFORM FROM SECTOR PERFORM; RAISES TARGET PRICE TO C$9 FROM C$7.5
- Web3: Bitcoin falls below $64,000, ETFs turn to net outflows
- GBP/USD Price Forecast: Holds Descending Triangle breakout
- Zura Bio posts corporate overview highlighting tibulizumab dual IL-17/BAFF bispecific program in Phase 2 development
- Qatar says Oman-Iran talks reach advanced stage
- A storage tank at Libya's main oil refinery was hit and caught fire.
- BRIEF-Neuronetics Q2 Operating Expenses USD 22.7 Million
- Neuronetics Q2 net loss narrows to $3.4 million; revenue rises 9.1% to $41.6 million vs Q2 2025
- Neuronetics 2Q Loss $3.44M >STIM
- Zenergy signs cooperation MoU with RSG Stockholm for modular housing projects pipeline of 360 apartments
- US Stock Movement | Beyond Meat Plunges 21% in Pre-market Trading
- SpectraCure chair Wennberg lifts stake to 2.66% voting rights after rights issue
- iShares Trust trims Adtran voting rights to 4.2% from 4.23%
- ClearSign appoints ex-ExxonMobil technology leader Larry Saddler to board
- Lasernet Group to delist from Nasdaq Stockholm; last trading day Aug. 24, 2026
- Signet names Jamie Cygielman president of Zales, Banter
- Neurogene publishes corporate presentation highlighting NGN-401 gene therapy program for Rett syndrome
- Metal Energy to issue 550,000 shares at C$0.89 in Centerra, Teck top-up placement
- $19 Billion AI Bet Backfires as Korean Retail Suffers Worst KOSPI Crash Since 2008
- Market News: The total assets under management in the German fund industry have surpassed €5 trillion for the first time.
- Nvidia’s $500B AI Infrastructure Push Could Deepen Divide With Decentralized Networks
- Natura publishes Q2 2026 results presentation
- Mermaid Maritime appoints Ms Chayanan Sakornsakolpat as company secretary
- Organigram Q3 FY2026 net revenue rises 49% to CAD 105.78 million, driven by Sanity Group contribution, company says
- Mermaid Maritime 1H FY26 net loss narrows 53.2% to USD 7.23 million
- Aura Biosciences releases corporate deck outlining bel-sar strategy in ocular oncology
- Littelfuse director Kelsey files initial beneficial ownership statement
- Mermaid Maritime enters 50:50 JV with DS Global to reactivate Mermaid Commander vessel
- COGENT BIOSCIENCES, INC. <COGT.O>: GUGGENHEIM RAISES TARGET PRICE TO $52 FROM $45
- Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases
- Ryman Hospitality plans USD 700 million senior notes offering due 2035
- Gelum Resources grants 1,100,000 stock options at $0.90 per share
- Metals Creek hits 7.25 g/t gold over 7.45 m at Ogden project in Ontario
- Incannex wins approval of overseas findings, secures A$5.1 million R&D tax refund
- CDN Maverick holds 3.3 million Noram Lithium shares, 1.65 million warrants in portfolio update
- NovaRed Mining reports trench samples up to 1.67% copper at Wilmac project in British Columbia
- Turnium Technology Group adopts TTGI as primary corporate brand identity
- Bicara Q2 FY26 net loss widens 102.4% to $55.44 million
- Littelfuse appoints Plexus CEO Todd Kelsey to board, names him to compensation panel
- Ambiq Q2 FY26 GAAP net loss narrows to $7.12 million; net sales rise 89.7% to $33.9 million year over year
- Eltek updates financial calendar with Q2 2026 earnings release and conference call schedule
- EVgo opens new flagship fast-charging site near GM technical center in Detroit metro area
- Stardust Power appoints Ray Rivers to board, names him to audit and compensation committees
- Sagimet net loss widens to $14 million in Q2 FY26; R&D expense climbs to $11.54 million
- Zura Bio Q2 FY26 net loss widens to $26.3 million; R&D expense more than doubled to $20.7 million
- BRIEF-Intensity Therapeutics Q2 Operating Income USD -3.084 Million
- Intensity Therapeutics 2Q Loss $3.01M >INTS
- BRIEF-Neurogene Q2 Operating Expenses USD 36.67 Million
- Intensity Therapeutics 2Q Loss/Shr $1.11 >INTS
- Neurogene 2Q Loss/Shr $1.53 >NGNE
- Neurogene 2Q Research & Development Expenses $25.5M >NGNE
- Bicara Names Jenn Larson CFO
- Veradermics Q2 FY26 net loss widens to $23.5 million; R&D expense rises to $18.61 million
- Neurogene Q2 FY26 net loss widens to USD 34.49 million
- Intermap appoints former OMERS CEO J. Michael Rolland to board
- Deep Sea Minerals welcomes Trump comment on authorizing deep-sea mining at US roundtable
- Algo Grande Copper logs expanded copper mineralization in Adelita Phase II Hole 2
- Bicara Therapeutics 2Q Loss/Shr 82c >BCAX
- Sagimet Biosciences 2Q Loss/Shr 26c >SGMT
- Zura Bio Expects Existing Cash and Cash Equivalents Sufficient to Support Planned Ops Through at Least End of 2028 >ZURA
- Ambiq Micro 2Q Loss/Shr 32c >AMBQ
- Ambiq Micro 2Q Sales $33.9M >AMBQ
- Zura Bio 2Q Loss $26.3M >ZURA
- Harvard Bioscience Sees 3Q Rev $21M-$22.6M >HBIO
- Hemab Therapeutics 2Q Research and Development Expenses $20.3M >COAG
- Xtant Medical Holdings Cuts 2026 View To Rev $99M-$103M >XTNT
- Fennec Pharmaceuticals 2Q Rev $17.9M >FRX.T
- Fennec Pharmaceuticals 2Q EPS 5c >FRX.T
- CalciMedica 2Q Loss/Shr 45c >CALC
- Terrestrial Energy 2Q Loss/Shr 9c >IMSR
- CalciMedica 2Q Research and Development Expenses $2.1M >CALC
- 908 Devices Narrows 2026 View To Rev $68.0M-$70.0M >MASS
- 908 Devices 2Q Loss/Shr 32c >MASS
- Aura Biosciences 2Q Loss/Shr 48c >AURA
- CVRx: Paul Verrastro to Assume Role of Interim Head of Sales, Effective Immediately >CVRX
